| ²é¿´: 1027 | »Ø¸´: 3 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
hupineÌú³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Ò½Ò©»¯Ñ§·½Ãæ ×Ô¼ºÒѾ·ÒëÁËÒ»°ë£¬»¹Óм¸¾ä»°»¹µÃÇë½ÌÄú£¬×¨ÒµÐÔÓеãÇ¿¡£
|
|
|
¼Ó´Ö²¿·ÖµÄ·ÒëÐèÒªÇëÄú°ïæ·Òë³ÉÓ¢ÎÄ£¬²¢ÇÒÏ£ÍûÄú°ïÎÒ¿´ÏÂÎҵķÒëÊÇ·ñÇ¡µ±£¡Ð»Ð» ßÅßáÃÀÐÁÊÇÒ»À࿹Ñ×»îÐÔ½ÏÇ¿µÄ·ÇçÞÌ忹Ñ×Ò©£¬µ«ÓÉÓÚËü¶Ô賦µÀµÄ´Ì¼¤ÐԽϴó£¬ÇҶԸι¦ÄÜ¡¢ÔìѪϵͳÒÔ¼°ÖÐÊàÉñ¾ÏµÍ³¶¼ÓнϴóµÄ¸±×÷Óã¬Òò´ËÐè¶ÔËü½øÐнṹ¸ÄÔ죬µÃµ½¸±×÷ÓÃÏà¶Ô½ÏµÍµÄßÅßáÀàÒ©Î̽ÌÖÆä¹¹Ð§¹ØÏµ¡£·½·¨£º¸ù¾ÝÒÑÉÏÊеÄßÅßáÃÀÐÁµÄ¹¹Ð§¹ØÏµÒÔ¼°·Ö×ÓÄ£ÄâÑо¿µÄ½á¹û£¬Éè¼ÆÁË2-¼×»ù-1-(1,3-¶þ¼×»ù-3-äå-1H-ßÁßò-5-¼×õ£»ù)-5-¼×Ñõ»ù-1H-ßÅßá-3-ÒÒËá¡£ÒÔ1,3-¶þ¼×»ù-3-äå-1H-ßÁßò-5-¼×ËáΪÔÁÏ£¬¾¶à²½·´Ó¦ºÏ³ÉÄ¿±ê»¯ºÏÎï¡£½á¹ûÓë½áÂÛ£ººÏ³ÉÁËδ¼ûÎÄÏ×±¨µÀµÄл¯ºÏÎËùÓÐÄ¿±ê»¯ºÏÎïµÄ½á¹¹¾IR 1H-NMR¡¢MSÆ×ºÍÔªËØ·ÖÎöÈ·Ö¤¡£ study the structure-activity relationships(SAR)of the title compounds£®. Methods: Based on the SAR of Indomethacin and related molecular modeling studies, 2-(1-(4-bromo-1,3-dimethyl-1H-pyrazole-5-carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid were designed and synthesized . With 4-bromo-1,3-dimethyl-1H-pyrazole-5-carboxylic acid as a raw material, a multi-step reaction to synthetic the target compound. Results and conclusion: did not see literature synthesized reported the new compounds, The structures of target compounds were confirmed by IR£¬1H¡ªNMR£¬MS spectra and elemental analysis. ßÅßáÃÀÐÁ Indomethacin ¶ÔÂȱ½¼×Ëá 4-Chlorobenzoic acid 1,3-¶þ¼×»ù-4-äå-1H-ßÁßò-5-¼×Ëá 4-bromo-1,3-dimethyl-1H-pyrazole-5-carboxylic acid ¶Ô¼×Ñõ»ù±½°· p-Anisidine ÑÇÁòËáÄÆ Sodium sulfite п·Û Zinc dust ¶Ô¼×Ñõ»ù±½ë»ÇËáÄÆ 2-(4-METHOXYPHENYL)HYDRAZINESULFONIC ACID SODIUM SALT MONOHYDRATE ¶þÂÈÑÇí¿ Thionyl chloride 1,3-¶þ¼×»ù-4-äå-1H-ßÁßò-5-¼×õ£ÂÈ 4-bromo-1,3-dimethyl-1H-pyrazole-5-carbonyl chloride ÒÒõ£±ûËá Levulinic acid 2-¼×»ù-1-(1,3-¶þ¼×»ù-4-äå-1H-ßÁßò-5-¼×õ£»ù)-5-¼×Ñõ»ù-1H-ßÅßá-3-ÒÒËá 2-(1-(4-bromo-1,3-dimethyl-1H-pyrazole-5-carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid [ Last edited by hupine on 2011-5-29 at 00:46 ] |
» ±¾Ìû@֪ͨ
» ²ÂÄãϲ»¶
286Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
085601Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
302Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985
ÒѾÓÐ5È˻ظ´
328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑоÀú
ÒѾÓÐ4È˻ظ´
»úеר˶325£¬Ñ°ÕÒµ÷¼ÁԺУ
ÒѾÓÐ5È˻ظ´
²ÄÁÏר˶306Ó¢Ò»Êý¶þ
ÒѾÓÐ6È˻ظ´
»ï°éÃÇ£¬×£ÎÒÉúÈÕ¿ìÀÖ°É
ÒѾÓÐ26È˻ظ´
333Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
0854¿ØÖƹ¤³Ì 359Çóµ÷¼Á ¿É¿çרҵ
ÒѾÓÐ9È˻ظ´
hupine
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5.3
- É¢½ð: 30
- Ìû×Ó: 56
- ÔÚÏß: 30.1Сʱ
- ³æºÅ: 1304233
- ×¢²á: 2011-05-23
- רҵ: ¸ß·Ö×Ӻϳɻ¯Ñ§
2Â¥2011-05-29 19:54:59
zxs1989
½ð³æ (ÖøÃûдÊÖ)
Dance with Google
- ·ÒëEPI: 27
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 1327.7
- É¢½ð: 4491
- ºì»¨: 26
- Ìû×Ó: 2150
- ÔÚÏß: 612.2Сʱ
- ³æºÅ: 1122965
- ×¢²á: 2010-10-15
- רҵ: Íâ¹úÓïÑÔ

3Â¥2011-05-30 01:20:30
zxs1989
½ð³æ (ÖøÃûдÊÖ)
Dance with Google
- ·ÒëEPI: 27
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 1327.7
- É¢½ð: 4491
- ºì»¨: 26
- Ìû×Ó: 2150
- ÔÚÏß: 612.2Сʱ
- ³æºÅ: 1122965
- ×¢²á: 2010-10-15
- רҵ: Íâ¹úÓïÑÔ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
hupine(½ð±Ò+13, ·ÒëEPI+1): ·Ç³£¸Ðл 2011-05-30 08:28:45
Mally89(½ð±Ò+2): ¸ÐлӦÖú£¡~»¶Ó³£À´£¡~ 2011-05-30 11:18:23
hupine(½ð±Ò+13, ·ÒëEPI+1): ·Ç³£¸Ðл 2011-05-30 08:28:45
Mally89(½ð±Ò+2): ¸ÐлӦÖú£¡~»¶Ó³£À´£¡~ 2011-05-30 11:18:23
|
Indomethacin, although a potent non-steroid antiinflammatory drug, has been known as a strong gastrointestine irritant and for its serious side effects on the liver function, the hemopoietic system, and the central nervous system. It¡¯s highly desirable to obtain indole drugs with relatively small adverse effects via structural reformation of indomethacin and to study their structure-activity relationships(SAR)£® Methods: Based on the SAR of indomethacin and related molecular modeling studies, 2-(1-(4-bromo-1,3-dimethyl-1H-pyrazole-5-carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid were designed and synthesized through a multi-step reaction from 4-bromo-1,3-dimethyl-1H-pyrazole-5-carboxylic acid. Results and conclusion: New indole compounds which have not been reported before were synthesized, and all their structures were confirmed by IR£¬1H¡ªNMR£¬MS, and elemental analysis. Âß¼¹ØÏµÉÔÓи͝¡£²¢Î´Ñϸñ°´ÕÕÐǪ̈µÄÖÐÎÄÖ±Òë |

4Â¥2011-05-30 02:32:48













»Ø¸´´ËÂ¥
Õâ¸öÇóÖúÌûÀ䳡ÁË